Trial record 1 of 1 for:    hepatocellular carcinoma sorafenib mFOLFOX
Previous Study | Return to List | Next Study

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01775501
Recruitment Status : Active, not recruiting
First Posted : January 25, 2013
Last Update Posted : April 24, 2018
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 2018
  Estimated Study Completion Date : December 2018